Samar S Andotra Selected Research

boswellic acid

12/2013	Reversal of boswellic acid analog BA145 induced caspase dependent apoptosis by PI3K inhibitor LY294002 and MEK inhibitor PD98059.
6/2013	NF-κB down-regulation and PARP cleavage by novel 3-α-butyryloxy-β-boswellic acid results in cancer cell specific apoptosis and in vivo tumor regression.
7/2012	PARP cleavage and perturbance in mitochondrial membrane potential by 3-α-propionyloxy-β-boswellic acid results in cancer cell death and tumor regression in murine models.
1/2011	A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase I & II inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samar S Andotra Research Topics

Disease

3	Neoplasms (Cancer) 12/2013 - 07/2012
2	Leukemia 12/2013 - 01/2011
1	Retinoblastoma (Glioblastoma, Retinal) 12/2013

Drug/Important Bio-Agent (IBA)

4	boswellic acidIBA 12/2013 - 01/2011
3	AcidsIBA 06/2013 - 01/2011
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 12/2013
1	Cell Cycle ProteinsIBA 12/2013
1	Cyclin EIBA 12/2013
1	Pentacyclic TriterpenesIBA 07/2012

Therapy/Procedure

1	Therapeutics 07/2012